However, it may casue decreased of appetite, diarrhea, and itching in some people
We can repeat this medical success story for semaglutide. The researchers warned that cheaper treatments would not address the structural drivers of obesity, including food insecurity, poverty, urbanisation and commercial food environments, and said that coordinated policies and procurement planning would be needed to realise the benefits
Cons and Considerations GLP-1 medications can be effective, but they are not a quick fix
Phase 3 TRIUMPH Program Status Building on the Phase 2 findings, Eli Lilly launched the TRIUMPH Phase 3 clinical program , a multi-trial initiative evaluating retatrutide across several conditions: TRIUMPH-1: Chronic weight management in adults with obesity or overweight with comorbidities
If you encounter any adverse effects, consult with a healthcare professional